Physicians’ knowledge of potential covid-19 drug–drug interactions: An online survey in turkey-Reference-Cited by-同舟云学术

Physicians’ knowledge of potential covid-19 drug–drug interactions: An online survey in turkey

Published:2020-08-25 Issue:2 Volume:133 Page:237-241
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Sürmelioğlu Nursel¹^ORCID,Yalçın Nadir²^ORCID,Kuşçu Ferit³^ORCID,Candevir Aslıhan³^ORCID,İnal Ayşe Seza³^ORCID,Kömür Süheyla³^ORCID,Kurtaran Behice³^ORCID,Demirkan Kutay²^ORCID,Taşova Yeşim³^ORCID

Affiliation:

1. Department of Clinical Pharmacy, Faculty of Pharmacy, Çukurova University, Adana, Turkey

2. Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey

3. Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Çukurova University, Adana, Turkey

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2020.1807809

Reference23 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. World Health Organization Coronavirus disease 2019 (COVID-19) Situation Report – 119. [cited 2020 May 18]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200518-covid-19-sitrep-119.pdf?sfvrsn=4bd9de25_4

3. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

4. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review;Expert Opinion on Drug Metabolism & Toxicology;2024-04-02

2. Physician characteristics associated with antiviral prescriptions for older adults with COVID-19 in Japan: an observational study;BMJ Open;2024-03

3. Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19;Expert Review of Anti-infective Therapy;2024-01-31

4. Drug-drug interactions between COVID-19 therapeutics and psychotropic medications;Expert Opinion on Drug Metabolism & Toxicology;2023-12-02

5. Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020);Frontiers in Pharmacology;2023-04-21